U.S. Pharma Stock News

NYSE:WRB
NYSE:WRBInsurance

Weighing W. R. Berkley (WRB) After Recent Share Price Weakness

If you are wondering whether W. R. Berkley is fairly priced or offering value right now, the starting point is to look closely at what the current share price actually reflects. The stock most recently closed at US$68.76, with returns of a 1.7% decline over 7 days, a 3.9% decline over 30 days, a 0.9% decline year to date, 11.7% over 1 year, 81.7% over 3 years and 135.1% over 5 years. This gives you a mix of short term weakness and longer term strength to weigh up. Recent news around W. R...
NasdaqGS:MRCY
NasdaqGS:MRCYAerospace & Defense

Mercury Systems Acquisition Brings Critical Manufacturing In House For Defense Programs

Mercury Systems (NasdaqGS:MRCY) has acquired SolderMask, Inc., adding specialized manufacturing capabilities and intellectual property. The deal brings in skilled personnel and assets that directly support more than 20 active Mercury programs tied to critical defense work. The acquisition is intended to accelerate production efficiency and strengthen delivery commitments across key customer contracts. Mercury Systems, trading at $78.16, has seen a 68.0% return over the past year and a 69.1%...
NasdaqGM:KYMR
NasdaqGM:KYMRBiotechs

Can Kymera Therapeutics’ (KYMR) Oral Degraders Redefine Its Long-Term Edge Over Biologic Rivals?

Kymera Therapeutics recently advanced its first IRF5-directed oral therapy, KT-579, into human clinical testing and reported Phase 1b data for its oral STAT6 degrader KT-621, which appeared comparable or better than injectable dupilumab in a large inflammatory disease market. This progress positions Kymera as a pioneer in oral protein degraders that aim to match biologic-like efficacy while potentially offering more convenient, small-molecule treatment options. We’ll now examine how Kymera’s...
NasdaqGS:TTEK
NasdaqGS:TTEKCommercial Services

Is Tetra Tech (TTEK) Attractive After Recent Share Price Pullback And Mixed Valuation Signals

If you are wondering whether Tetra Tech shares are offering fair value right now, this article walks through what the current price could mean for long term investors. The stock last closed at US$32.18, with a 7.7% decline over the past week, a 20.4% decline over the past month, and returns of 11.3% over 1 year, 17.9% over 3 years, and 28.8% over 5 years. Recent coverage has focused on Tetra Tech as a US listed commercial services company and on how its current share price compares with...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

Is Rezdiffra’s Near‑US$1 Billion Debut Reshaping The Investment Case For Madrigal Pharmaceuticals (MDGL)?

Madrigal Pharmaceuticals recently reported that its MASH drug Rezdiffra generated nearly US$1.00 billion in its first full year on the market, reinforcing the company’s leading position in this disease area. This rapid commercial traction, coupled with management’s expectation for continued robust net sales growth in 2026, has attracted heightened attention from both institutional investors and short-sellers. Next, we’ll examine how Rezdiffra’s nearly US$1.00 billion first-year sales...
NYSE:PIPR
NYSE:PIPRCapital Markets

Assessing Piper Sandler (PIPR) After Recent Share Price Weakness And Capital Markets Activity

If you are wondering whether Piper Sandler Companies' current share price really reflects its underlying worth, or if the recent run leaves room for value, this article walks through that question step by step. The stock last closed at US$282.30, with returns showing a 3.8% decline over 7 days, a 17.4% decline over 30 days, a 19.3% decline year to date, a 14.2% gain over 1 year and a very large 3 year and 5 year return. Recent coverage around Piper Sandler Companies has focused on its role...
NYSE:U
NYSE:USoftware

Unity Insider Selling Raises Questions As Margins Improve And Growth Slows

Unity Software (NYSE:U) has seen significant insider selling activity while reporting expanding operating margins. At the same time, the company is working through revenue growth challenges that have drawn fresh attention from investors. The mix of insider sales, margin improvement, and pressure on growth is raising new questions about Unity's internal outlook and business direction. For investors watching Unity Software at a share price of $19.43, the recent pattern of insider selling...
NasdaqGM:LFMD
NasdaqGM:LFMDHealthcare Services

LifeMD (LFMD) Is Up 32.7% After Returning To Profitability And Expanding GLP‑1 Telehealth Offerings

In early March 2026, LifeMD, Inc. reported that it moved from a US$21.41 million annual net loss in 2024 to US$14.35 million net income in 2025, issued double‑digit revenue growth guidance for 2026, and highlighted expanding telehealth offerings including its oral Wegovy weight management launch with Novo Nordisk. This shift to profitability, combined with more than 322,000 active subscribers and growing GLP‑1 and women’s health programs, signals a business model that is scaling across...
NasdaqGS:NTAP
NasdaqGS:NTAPTech

Does The Recent Pullback Make NetApp (NTAP) Look Attractive On Valuation Grounds?

If you are wondering whether NetApp's share price really reflects what the business is worth today, you are not alone. That is exactly what this article will unpack. NetApp shares last closed at US$98.66, with returns of 9.5% over 1 year, 71.3% over 3 years and 58.3% over 5 years. However, the stock has seen a 2.4% decline over 7 days, 6.8% over 30 days and 7.3% year to date. Recent company specific headlines have continued to keep investor attention on NetApp, helping frame how the market...
NYSE:PRU
NYSE:PRUInsurance

PGIM Awards Put Fresh Focus On Prudential Financial’s Valuation And Mix

PGIM, the global investment management arm of Prudential Financial (NYSE:PRU), received multiple 2026 LSEG Lipper Fund Awards. The awards recognize consistent, risk adjusted performance across PGIM funds. The recognition extends Prudential Financial's record of industry accolades for its asset management platform. For a company often associated first with insurance and annuities, these LSEG Lipper Fund Awards put a spotlight on a different side of Prudential Financial: its global asset...
NasdaqGS:MAPS
NasdaqGS:MAPSSoftware

WM Technology (MAPS) Margin Compression To 1.1% Tests Bullish Earnings Narratives

WM Technology (MAPS) closed out FY 2025 with Q4 revenue of about US$43.1 million and a basic EPS loss of roughly US$0.03, while trailing twelve month EPS stood at around US$0.02 on revenue of roughly US$174.7 million. Over recent periods the company has seen quarterly revenue range between about US$42.2 million and US$47.7 million, with EPS moving from a profit of roughly US$0.03 per share in late 2024 to small profits through most of 2025 before the latest quarterly loss. This has left...
NYSE:MC
NYSE:MCCapital Markets

Is It Time To Revisit Moelis (MC) After The Recent Share Price Slump

If you are wondering whether Moelis shares offer good value at today's price, it helps to step back and look at what the current market is implying about the business. The stock last closed at US$51.75, after a 7.8% decline over the past week, a 25.1% decline over the past month, and a 27.3% decline year to date, while still showing a 51.6% return over 3 years and 23.6% over 5 years. These recent moves have kept Moelis on investors' radars, with market commentary often linking advisory firms...
NYSE:UTZ
NYSE:UTZFood

Assessing Utz Brands (UTZ) Valuation After Recent Share Price Pullback

Why Utz Brands Stock Is On Investors’ Radar Utz Brands (UTZ) has drawn fresh attention after a sharp share price pullback, with the stock around $7.56 and showing negative returns over the past month and past 3 months. See our latest analysis for Utz Brands. The recent pullback has been steep, with a 30 day share price return of a 32.08% decline and a 90 day share price return of a 26.10% decline. Over the longer term, the 1 year total shareholder return of a 41.97% decline points to...
NasdaqCM:IMUX
NasdaqCM:IMUXBiotechs

Should Extended European Patent Protection for Vidofludimus Calcium Reshape Immunic’s (IMUX) Long-Term Value Proposition?

Immunic, Inc. recently secured a key European patent for its lead asset vidofludimus calcium, aligning protection with existing U.S. coverage and potentially extending exclusivity into the 2040s for chronic inflammatory and autoimmune indications. This expanded intellectual property protection materially underpins the company’s core therapeutic franchise by lengthening its runway to develop and, if approved, commercialize its main clinical asset. Against this backdrop, we’ll explore how the...
NasdaqGM:FUTU
NasdaqGM:FUTUCapital Markets

Is Futu Holdings (FUTU) Pricing Reflect A 20.9% YTD Drop And Valuation Upside Potential

If you are wondering whether Futu Holdings is attractively priced or getting ahead of itself, this article will walk through what the current share price might be implying about its value. The stock last closed at US$141.14, with returns of 19.1% over 1 year and a very large 3 year gain. However, the year to date return sits at a 20.9% decline and the 30 day return at an 8.8% decline. Recent coverage has focused on Futu Holdings as a major online brokerage name listed on the Nasdaq, with...
NasdaqCM:DTIL
NasdaqCM:DTILBiotechs

Precision BioSciences (DTIL) Q4 Profit Of US$19.2m Challenges Ongoing Loss Narrative

Precision BioSciences (DTIL) closed out FY 2025 with Q4 revenue of US$34.2 million and Basic EPS of US$1.01, alongside earnings from discontinued operations of US$0.9 million and net income excluding extra items of US$19.2 million. Over recent quarters, the company has seen revenue range from US$0.6 million in Q4 2024 to US$34.2 million in Q4 2025. Over the same period, quarterly Basic EPS has moved from a loss of US$2.22 in Q4 2024 to a profit of US$1.01 in Q4 2025. This sets up an earnings...
NasdaqGS:SBLK
NasdaqGS:SBLKShipping

Does Star Bulk Carriers’ (SBLK) New Visibility Reframe Its Long‑Term Risk and Strategy Narrative?

Star Bulk Carriers recently attracted investor attention after appearing among Zacks.com’s most searched stocks and participating in Capital Link’s online maritime company presentations, where management discussed its business development, strategy, and sector outlook in a live webinar and Q&A. This combination of heightened visibility and a stable earnings outlook, including expectations for significant year-over-year earnings growth, has sharpened focus on how management’s messaging aligns...
NYSE:AIZ
NYSE:AIZInsurance

The Bull Case For Assurant (AIZ) Could Change Following Strong Q4 Beat And 2026 Outlook Update

Assurant, Inc. reported fourth-quarter 2025 net operating income and revenue above analyst estimates, driven by higher premiums and growth in its Global Housing and Global Lifestyle segments, and outlined 2026 adjusted EBITDA expectations that are consistent with or higher than 2025 alongside continued capital returns to shareholders. Separately, Assurant expanded access to its Reynolds and Reynolds docuPAD eContracting training program and announced that experienced financial services...
NYSE:TIC
NYSE:TICProfessional Services

TIC Solutions CEO Change And US$200m Buyback Reframe Turnaround Story

TIC Solutions (NYSE:TIC) has appointed Ben Heraud as its new CEO, succeeding long-serving leader Tal Pizzey. The company has also launched a $200 million share repurchase program. These changes were recently announced and have not been widely discussed in prior coverage. TIC Solutions is making these moves at a time when its share price is $7.25, with the stock showing a 40.3% decline over the past year and a 26.7% decline year to date. The new leadership and buyback plan arrive against...
NasdaqGS:EVCM
NasdaqGS:EVCMSoftware

EverCommerce (EVCM) Profitability Milestone Tests Bullish Narratives On Margin Sustainability

EverCommerce (EVCM) has wrapped up FY 2025 with fourth quarter revenue of US$151.2 million and basic EPS of US$0.03, alongside net income from ongoing operations of US$5.7 million. This caps a trailing twelve month period with revenue of US$588.9 million and EPS of US$0.10. Over recent quarters the company has seen revenue range from US$142.3 million to US$151.2 million, with quarterly EPS between US$0.01 and US$0.03. Over the same period, trailing twelve month net income from ongoing...
NYSE:FVRR
NYSE:FVRRProfessional Services

Is Fiverr (FVRR) Pricing Reflect Recent Share Slump Accurately

If you are wondering whether Fiverr International's current share price reflects its true worth, you are not alone. This article will walk you through what the numbers are actually saying about value. The stock has seen sizeable declines recently, with a 7.7% fall over the last week, a 27.6% decline over the last month, a 46.8% drop year to date, and a 59.2% decline over the past year. This extends a 68.5% and 95.3% fall across the last 3 and 5 years respectively. Recent attention on Fiverr...
NYSE:SM
NYSE:SMOil and Gas

SM Energy Eagle Ford Sale Reshapes Debt Profile And Growth Options

SM Energy (NYSE:SM) has agreed to sell a package of Eagle Ford assets for $950 million. The sale forms a major part of the company's $1b divestment program. Proceeds are expected to be used to reduce debt and reshape SM Energy's asset portfolio. For shareholders, this transaction comes with NYSE:SM trading at $26.79 and showing a mixed return profile. The stock is up 3.2% over the past week and 22.3% over the past month, with a 40.0% return year to date, yet it shows a 6.6% decline over the...
NYSE:RH
NYSE:RHSpecialty Retail

Does RH (NYSE:RH) Share Price Slump Present A Valuation Opportunity?

If you are wondering whether RH's current share price reflects its true worth, you are not alone. This article will walk through what the numbers are saying about the stock's value today. RH shares last closed at US$128.37, after returns of a 9.7% decline over 7 days, a 35.8% decline over 30 days, a 33.6% decline year to date, a 43.0% decline over 1 year, a 47.9% decline over 3 years and a 75.1% decline over 5 years. Recent coverage around RH has focused on how the company is positioned...
NYSE:DCI
NYSE:DCIMachinery

Donaldson Acquisition Of Facet Shifts Focus Toward Critical Filtration Growth

Donaldson Company (NYSE:DCI) has agreed to acquire Facet, a provider of filtration solutions for aerospace, defense, and power generation. The deal is intended to expand Donaldson's product lineup and deepen its presence in durable end markets tied to critical infrastructure and equipment. The acquisition adds exposure to customers that require highly technical filtration in mission critical applications. Donaldson Company focuses on filtration technologies across industrial, engine, and...